Grants & Projects per year
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Targeting the IL-23 Inflammatory Pathway n Duchenne Muscular Dystrophy
Morales, M. (PI)
Foundation to Eradicate Duchenne
01/1/26 → 12/31/26
Project: Research
-
Understanding the molecular basis for corticosteriods efficacy in DMD:Indentifying partial correlations network across lipidomic, proteomic, and moto function profiles using Vamorolone VBP15-004 clinical trial data
Fang, Y. (PI) & Morales, M. (PI)
Foundation to Eradicate Duchenne
01/1/25 → 12/31/26
Project: Research
-
SH Ho Innovation Research Endowment-
Chiarot, P. (CoI), Huang, P.-Y. (CoI), Koh, A. (CoI), Mativetsky, J. (CoI), Morales, M. (CoI), Qiang, W. (CoI), Rao, S. (CoI), Su, M. (CoI), Hall, D. (PI), Cook, L. (CoI), Guo, N. (CoI), Hookway, T. (CoI), Li, Y. (CoI), Miles, R. (CoI), Zeng, Y. (CoI), Zhou, J. (CoI) & Wang, Y. (CoI)
Foundation of SUNY at Binghamton
01/1/24 → 09/30/27
Project: Research
-
Ceramide Pathway Dysregulation in Duchenne Muscular Dystrophy
Morales, M. (PI)
Foundation to Eradicate Duchenne
01/1/24 → 12/31/25
Project: Research
-
Investigating the Role of Type I Interferon Signaling on Muscle Disease Using Mouse Models
Spathis, R., Narvesen, S., Robles Kuriplach, D., Huang, K., Sundar, T., Bagley, E., Parkes, J., Jia, X., Sudhan, N., Guzman, A., Nagaraju, K. & Morales, M., Sep 2026, In: Arthritis and Rheumatology. 78, 9, p. 1942-1951 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Corrigendum: Enhancing AAV-microdystrophin gene therapy after repeat dosing by blocking phagocytosis (Frontiers in Immunology, (2025), 16, (1527840), 10.3389/fimmu.2025.1527840)
Spathis, R., Kuriplach, D. R., Narvesen, S., Eybs, M., Huang, K., Torres, S., King, M., Bagley, E., Elustondo, P., Lawlor, M. W., Nagaraju, K. & Morales, M., 2025, In: Frontiers in Immunology. 16, 1593193.Research output: Contribution to journal › Comment/debate
Open Access1 Scopus citations -
Enhancing AAV-microdystrophin gene therapy after repeat dosing by blocking phagocytosis
Spathis, R., Kuriplach, D. R., Narvesen, S., Eybs, M., Huang, K., Torres, S., King, M., Bagley, E., Elustondo, P., Lawlor, M. W., Nagaraju, K. & Morales, M., 2025, In: Frontiers in Immunology. 16, 1527840.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Urine proteomics by mass spectrometry identifies proteins involved in key pathogenic pathways in patients with juvenile dermatomyositis
Morales, M., Alayi, T. D., Tawalbeh, S. M., Sydenstricker, A. V., Spathis, R., Kim, H., Nagaraju, K., Hathout, Y. & Rider, L. G., Sep 1 2023, In: Rheumatology (United Kingdom). 62, 9, p. 3161-3168 8 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Targeting necroptosis for the treatment of myositis
Nagaraju, K. & Morales, M., Jun 2022, In: Nature Reviews Rheumatology. 18, 6, p. 307-308 2 p.Research output: Contribution to journal › Comment/debate
1 Scopus citations